Brickell's sofpironium bromide meets in Phase IIb for hyperhidrosis

In October, Brickell Biotech Inc. (Boulder, Colo.) reported data from a double-blind, U.S. Phase IIb trial in 227 patients with primary axillary hyperhidrosis showing that 5%,

Read the full 261 word article

User Sign In